Centrient Holding B.V. - S&P Global Ratings’ Credit Research

Centrient Holding B.V.

Centrient Holding B.V. - S&P Global Ratings’ Credit Research
Centrient Holding B.V.
Published Dec 14, 2022
9 pages (3836 words) — Published Dec 14, 2022
Price US$ 500.00  |  Buy this Report Now

About This Report

  
Abstract:

Overview Key strengths Key risks Leading position in its addressable market based on technology with high barriers to entry. Business risk profile constrained by small size and limited product diversity. Ability to apply pricing premiums in some of its addressable markets, thanks to its patented enzymatic fermentation process. Subject to stringent manufacturing standards and with limited facilities. Low-cost positioning compared with peers and longstanding relationships with customers. Continued pricing and volume pressure, coupled with changing regulatory environments in some of its addressable markets. Solid track record of regulatory compliance. Near-term refinancing risks for the revolving credit facility (RCF), with maturity in the next 24 months. Adjusted EBITDA margins of 12%-14% in S&P Global Ratings? base case, supported by ability to

  
Brief Excerpt:

...S&P Global Ratings expects Centrient's profitability will gradually improve to about 12%-13% in 2022 from the much decreased level in 2021, thanks to volume demand recovery coupled with the company's efforts to protect its margins. EBITDA margin improvement will mainly stem from volume pick-up across the company's offerings, especially statins, with the opening of new manufacturing sites in Navrang (India) underpinning demand recovery from previous low levels in 2021 (caused by overstocking from...

  
Report Type:

Full Report

Issuer
GICS
Pharmaceuticals (35202010)
Sector
Global Issuers
Country
Region
Europe, Middle East, Africa
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Centrient Holding B.V." Dec 14, 2022. Alacra Store. May 23, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Centrient-Holding-B-V-2929167>
  
APA:
S&P Global Ratings’ Credit Research. (). Centrient Holding B.V. Dec 14, 2022. New York, NY: Alacra Store. Retrieved May 23, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Centrient-Holding-B-V-2929167>
  
US$ 500.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.